“Yiqi Huayu, Wenyang Lishui” Prescription (YHWLP) Improves the Symptoms of Chronic Obstructive Pulmonary Disease-Induced Chronic Pulmonary Heart Disease by Inhibiting the RhoA/ROCK Signaling Pathway

Table 2

Comparison of increases in pulmonary function (relative to baseline) between the two groups.

Group	FEV1	FVC	FEV1/FVC	FEV1%
YHWLP (n = 40)	0.39 ± 0.15	0.39 ± 0.28	6.35 ± 2.74	6.11 ± 3.49
Control (n = 40)	0.04 ± 0.01	0.21 ± 0.11	1.56 ± 0.52	4.72 ± 5.10

Notes: FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; FEV1%, FEV1 as a percentage of predicted value. Values are mean ± standard deviation. , , .